collection
MENU ▼
Read by QxMD icon Read
search

Statistics, Investigation, Publication and Gender Academic Differences in Nephrology

shared collection
401 papers 100 to 500 followers
By Isabel Acosta-Ochoa Nephrology senior staff. Valladolid. Spain
https://read.qxmd.com/read/30739694/organisational-best-practices-towards-gender-equality-in-science-and-medicine
#1
REVIEW
Imogen R Coe, Ryan Wiley, Linda-Gail Bekker
In August 2018, the president of the World Bank noted that "'Human capital'-the potential of individuals-is going to be the most important long-term investment any country can make for its people's future prosperity and quality of life". Nevertheless, leaders and practitioners in academic science and medicine continue to be unaware of and poorly educated about the nature, extent, and impact of barriers to full participation of women and minorities in science and medicine around the world. This lack of awareness and education results in failures to fully mobilise the human capital of half the population and limits global technological and medical advancements...
February 9, 2019: Lancet
https://read.qxmd.com/read/30867145/bureaucracy-is-strangling-clinical-research
#2
Simon Rule, Steven LeGouill
No abstract text is available yet for this article.
March 13, 2019: BMJ: British Medical Journal
https://read.qxmd.com/read/30856654/graphical-depiction-of-longitudinal-study-designs-in-health-care-databases
#3
Sebastian Schneeweiss, Jeremy A Rassen, Jeffrey S Brown, Kenneth J Rothman, Laura Happe, Peter Arlett, Gerald Dal Pan, Wim Goettsch, William Murk, Shirley V Wang
Pharmacoepidemiologic and pharmacoeconomic analysis of health care databases has become a vital source of evidence to support health care decision making and efficient management of health care organizations. However, decision makers often consider studies done in nonrandomized health care databases more difficult to review than randomized trials because many design choices need to be considered. This is perceived as an important barrier to decision making about the effectiveness and safety of medical products...
March 12, 2019: Annals of Internal Medicine
https://read.qxmd.com/read/30855638/overview-of-cost-effectiveness-analysis
#4
Gillian D Sanders, Matthew L Maciejewski, Anirban Basu
No abstract text is available yet for this article.
March 11, 2019: JAMA: the Journal of the American Medical Association
https://read.qxmd.com/read/30848814/marginal-effects-quantifying-the-effect-of-changes-in-risk-factors-in-logistic-regression-models
#5
Edward C Norton, Bryan E Dowd, Matthew L Maciejewski
No abstract text is available yet for this article.
March 8, 2019: JAMA: the Journal of the American Medical Association
https://read.qxmd.com/read/30846442/health-organisations-are-slow-to-tackle-gender-inequality-in-workforce-report-finds
#6
Adrian O'Dowd
No abstract text is available yet for this article.
March 7, 2019: BMJ: British Medical Journal
https://read.qxmd.com/read/30670641/a-network-s-gender-composition-and-communication-pattern-predict-women-s-leadership-success
#7
Yang Yang, Nitesh V Chawla, Brian Uzzi
Many leaders today do not rise through the ranks but are recruited directly out of graduate programs into leadership positions. We use a quasi-experiment and instrumental-variable regression to understand the link between students' graduate school social networks and placement into leadership positions of varying levels of authority. Our data measure students' personal characteristics and academic performance, as well as their social network information drawn from 4.5 million email correspondences among hundreds of students who were placed directly into leadership positions...
February 5, 2019: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/30837216/time-s-up-healthcare-can-we-put-an-end-to-gender-inequality-and-harassment-in-medicine
#8
Rhonda Acholonu, Christina Mangurian, Eleni Linos
No abstract text is available yet for this article.
March 5, 2019: BMJ: British Medical Journal
https://read.qxmd.com/read/30473063/-what-do-registries-compared-to-clinical-trials-tell-us
#9
Gabriel Choukroun, Bruno Moulin
The objective of this review is to illustrate the interests of registries in terms of clinical research, using practical examples from the French REIN registry. In addition to their interest in terms of observation and decision-making for public health, registries may also be used to compare structures, and to evaluate causality in clinical research. Indeed, even though randomized controlled trials are the gold standard to assess causality, they may be difficult to perform, with an applicability in daily life that remains to be demonstrated since patients are highly selected patients with a very close follow-up...
November 2018: Néphrologie & Thérapeutique
https://read.qxmd.com/read/30801508/glass-slippers-and-glass-cliffs-fitting-in-and-falling-off
#10
Nithya Krishnan, Deborah Biggerstaff, Ala Szczepura, Monica Dolton, Sondra Livingston, John Hattersley, Josette Eris, Nancy Ascher, Robert Higgins, Hillary J Braun, Kathryn Wood, Neil Raymond
BACKGROUND: A 'glass-ceiling' effect exists for women in male-dominated professions. Recent studies also show a 'glass-cliff' effect where senior women can more easily fall from positions of leadership. Transplantation remains a male-dominated specialty. This study investigated gender and the perception of adverse clinical incidents in transplantation. METHODS: Web-based survey involving five clinical scenarios which described errors or mistakes with male or female named protagonists...
February 18, 2019: Transplantation
https://read.qxmd.com/read/30789668/choosing-a-time-horizon-in-cost-and-cost-effectiveness-analyses
#11
Anirban Basu, Matthew L Maciejewski
No abstract text is available yet for this article.
February 21, 2019: JAMA: the Journal of the American Medical Association
https://read.qxmd.com/read/30651627/women-who-win-prizes-get-less-money-and-prestige
#12
Yifang Ma, Diego F M Oliveira, Teresa K Woodruff, Brian Uzzi
No abstract text is available yet for this article.
January 2019: Nature
https://read.qxmd.com/read/30760923/large-teams-develop-and-small-teams-disrupt-science-and-technology
#13
Lingfei Wu, Dashun Wang, James A Evans
One of the most universal trends in science and technology today is the growth of large teams in all areas, as solitary researchers and small teams diminish in prevalence1-3 . Increases in team size have been attributed to the specialization of scientific activities3 , improvements in communication technology4,5 , or the complexity of modern problems that require interdisciplinary solutions6-8 . This shift in team size raises the question of whether and how the character of the science and technology produced by large teams differs from that of small teams...
February 13, 2019: Nature
https://read.qxmd.com/read/30768569/a-systematic-review-for-variables-to-be-collected-in-a-transplant-database-for-improving-risk-prediction
#14
Jehad Almasri, Mouaffaa Tello, Raed Benkhadra, Allison S Morrow, Bashar Hasan, Wigdan Farah, Neri Alvarez Villalobos, Khaled Mohammed, Jay-Sheree P Allen, Larry J Prokop, Zhen Wang, Bertram L Kasiske, Ajay K Israni, Mohammad Hassan Murad
BACKGROUND: This systematic review was commissioned to identify new variables associated with transplant outcomes that are not currently collected by the Organ Procurement and Transplantation Network (OPTN). METHODS: We identified 81 unique studies including 1,193,410 patients with median follow-up of 36 months posttransplant, reporting 108 unique risk factors. RESULTS: Most risk factors (104) were recipient-related; few (4) were donor-related...
February 6, 2019: Transplantation
https://read.qxmd.com/read/30746127/citation-classics-ranking-of-the-top-100-most-cited-articles-in-nephrology
#15
Vincenzo Montinaro, Marica Giliberti, Chiara Villani, Adriano Montinaro
Background: The number of citations of a scientific article is considered a weight of that work in the field of interest. Bibliometric analysis of the most cited articles conducted in some medical disciplines has identified the most relevant scientific contributions that pushed forward knowledge and clinical practice of that discipline. Methods: We conducted a bibliometric analysis of the most cited articles in nephrology, by extracting relevant words that identify issues of nephrological interest and querying the Google Scholar database...
February 2019: Clinical Kidney Journal
https://read.qxmd.com/read/30730545/number-needed-to-treat-conveying-the-likelihood-of-a-therapeutic-effect
#16
Jeffrey L Saver, Roger J Lewis
No abstract text is available yet for this article.
February 7, 2019: JAMA: the Journal of the American Medical Association
https://read.qxmd.com/read/30712703/the-business-of-academic-publishing-a-catastrophe
#17
Richard Smith
No abstract text is available yet for this article.
October 6, 2018: Lancet
https://read.qxmd.com/read/30568218/how-to-give-a-great-scientific-talk
#18
Nic Fleming
No abstract text is available yet for this article.
December 2018: Nature
https://read.qxmd.com/read/30675427/the-establishment-and-validation-of-novel-therapeutic-targets-to-retard-progression-of-chronic-kidney-disease
#19
REVIEW
Carol Pollock, Anna Zuk, Hans-Joachim Anders, Mohammad Reza Ganji, David W Johnson, Bertram Kasiske, Robyn G Langham, Roberto Pecoits-Filho, Giuseppe Remuzzi, Jerome Rossert, Yusuke Suzuki, Tetsuhiro Tanaka, Robert Walker, Chih-Wei Yang, Joseph V Bonventre
The focus of this article is to define goals and resulting action plans that can be collectively embraced by interested stakeholders to facilitate new therapeutic approaches to mitigate chronic kidney disease progression. The specific goals include identifying druggable targets, increasing the capacity for preclinical and early clinical development, broadening the availability of new therapeutic approaches, and increasing investment in the development of new therapies to limit chronic kidney disease. Key deliverables include the establishment of new regional, national, and global consortia; development of clinical trial networks; and creation of programs to support the temporary mutual movement of scientists between academia and the biotechnology and pharmaceutical sector...
October 2017: Kidney International Supplements
https://read.qxmd.com/read/30675428/action-plan-for-optimizing-the-design-of-clinical-trials-in-chronic-kidney-disease
#20
REVIEW
Vlado Perkovic, Jonathan C Craig, Worawon Chailimpamontree, Caroline S Fox, Guillermo Garcia-Garcia, Mohammed Benghanem Gharbi, Meg J Jardine, Ikechi G Okpechi, Neesh Pannu, Benedicte Stengel, Katherine R Tuttle, Katrin Uhlig, Andrew S Levey
High-quality clinical trials are the cornerstone of evidence-based prevention and treatment of a disease, but nephrology has a strikingly weak base of such trials. Building the evidence base to improve outcomes for people with a kidney disease, therefore, requires both greater quantity and quality of clinical trials. To address these issues, we propose that we aim to enroll 30% of people with chronic kidney disease in trials by 2030. Goal 1: Strongly encourage and promote the conduct of clinical trials in people with chronic kidney disease to increase the number of clinical trials conducted...
October 2017: Kidney International Supplements
label_collection
label_collection
1755
1
2
2019-01-27 11:19:21
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"